Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

SAF-HOLLAND Aktie 55990017 / DE000SAFH001

11.11.2025 11:41:03

EQS-News: SAF-HOLLAND approves share buyback program with a volume of up to EUR 40 million

EQS-News: SAF-HOLLAND SE / Key word(s): Share Buyback
SAF-HOLLAND approves share buyback program with a volume of up to EUR 40 million

11.11.2025 / 11:41 CET/CEST
The issuer is solely responsible for the content of this announcement.


SAF-HOLLAND approves share buyback program with a volume of up to EUR 40 million

 

Bessenbach, November 11, 2025. The Management Board of SAF-HOLLAND SE ("SAF-HOLLAND"), one of the world's leading suppliers of trailer and truck components, today decided, with the approval of the Supervisory Board, to execute a share buyback program with a total volume of up to EUR 40 million (excluding incidental acquisition costs), which is expected to be carried out between the end of November 2025 and December 31, 2026.

Against the backdrop of a robust liquidity situation and a solid financing structure with no outstanding maturities before March 2027, the Company plans to repurchase its own shares in accordance with the safe harbor provisions of Article 5 of Regulation (EU) No. 596/2014 (Market Abuse Regulation) in conjunction with the provisions of Delegated Regulation (EU) 2016/1052.

Frank Lorenz-Dietz, Chief Financial Officer of SAF-HOLLAND SE, comments: "With the share buyback, we are underlining our confidence in the strength and future viability of SAF-HOLLAND. We consider the repurchase of our own shares to be an attractive investment in our company and a clear signal of our confidence in its long-term growth potential. At the same time, we are reaffirming our commitment to creating sustainable value for our shareholders."

The share buyback program is based on the authorization granted by the Annual General Meeting of SAF-HOLLAND SE on June 10, 2021, according to which the Management Board, with the approval of the Supervisory Board, may acquire treasury shares representing up to 10 percent of the share capital until June 9, 2026. The Company plans to propose to the Annual General Meeting on May 21, 2026, that the authorization to acquire treasury shares be renewed.

SAF-HOLLAND reserves the right to suspend, resume, or terminate the share buyback program at any time, to the extent permitted by law. Further details on the technical implementation of the buyback will be published in due course in an announcement pursuant to Art. 5 (1) (a) of the Market Abuse Regulation and Art. 2 (1) of Delegated Regulation (EU) 2016/1052.

 

Contact:

 

Dana Unger      

VP Investor Relations, Corporate & ESG Communications

Phone: +49 6095 301 949

dana.unger@safholland.de

 

Alexander Pöschl 

Senior Manager Investor Relations, Corporate & ESG Communications

Phone: +49 6095 301 117

alexander.poeschl@safholland.de

 

Michael Schickling

Senior Manager Investor Relations, Corporate & ESG Communications

Phone: +49 6095 301 617

michael.schickling@safholland.de

 

 

About SAF-HOLLAND

SAF-HOLLAND SE is a leading international manufacturer of chassis-related assemblies and components for trailers, trucks and buses. An average of around 5,700 dedicated employees worldwide generated sales of EUR 1,877 million in 2024.

The product range includes axle and suspension systems for trailers as well as fifth wheels and coupling systems for trucks, trailers, and semi-trailers as well as brake and EBS systems. In addition, SAF-HOLLAND also develops innovative products to increase the efficiency, safety, and environmental friendliness of commercial vehicles. With the brands SAF, Holland, Haldex, Assali Stefen, KLL, Neway, Tecma, V.Orlandi and York, the Group achieved strong market positions in the top three positions in the most important regions worldwide in 2024.

SAF-HOLLAND supplies manufacturers in the original equipment market on six continents. In the aftermarket business, the company supplies spare parts to manufacturers’ service networks and wholesalers as well as to end customers and service centers via an extensive global distribution network.

SAF-HOLLAND SE is listed in the Prime Standard of the Frankfurt Stock Exchange and is included in the SDAX (ISIN: DE000SAFH001). Further information is available at www.safholland.com.

 



11.11.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: SAF-HOLLAND SE
Hauptstrasse 26
63856 Bessenbach
Germany
Phone: +49 6095 301-949
E-mail: ir@safholland.de
Internet: www.safholland.com
ISIN: DE000SAFH001
WKN: SAFH00
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2227708

 
End of News EQS News Service

2227708  11.11.2025 CET/CEST

Analysen zu SAF-HOLLAND SE

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
04.11.25 SAF-HOLLAND Kaufen DZ BANK
04.11.25 SAF-HOLLAND Buy Warburg Research
29.10.25 SAF-HOLLAND Buy Hauck Aufhäuser Lampe Privatbank AG
16.10.25 SAF-HOLLAND Hold Deutsche Bank AG
16.10.25 SAF-HOLLAND Buy Warburg Research
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Mittwoch um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest

Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.

Schnell noch Plätze sichern!

Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer

Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉

Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.

💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abnehmspritzen – Ist der Hype vorbei? – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’101.52 19.93 SXBBOU
Short 13’385.87 13.69 QIUBSU
Short 13’884.77 8.83 UJ3S8U
SMI-Kurs: 12’620.21 11.11.2025 14:49:26
Long 12’102.65 19.77 SN3BLU
Long 11’840.64 13.99 S9HB2U
Long 11’318.03 8.86 SEPBTU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com